Intravesical therapy for urothelial carcinoma of the bladder

M. Manoharan

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Transurethral resection is an effective therapy for non-muscle-invasive bladder cancer. However, the high rates of recurrence and significant risk of progression in higher grade tumors mandates additional therapy with intravesical agents. In this review we discuss the role of various intravesical agents currently in use including the immunomodualtory agent BCG and chemotherapeutic agents. We discuss the current guidelines and the role of these therapeutic agents in the context of higher grade Ta and T1 tumors.

Original languageEnglish (US)
Pages (from-to)252-261
Number of pages10
JournalIndian Journal of Urology
Volume27
Issue number2
DOIs
StatePublished - Apr 1 2011

    Fingerprint

Keywords

  • Bladder
  • cancer
  • chemotherapy
  • intravesical

ASJC Scopus subject areas

  • Urology

Cite this